BNP Paribas Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.2K Sell
2,382
-392
-14% -$2.61K ﹤0.01% 2048
2026
Q1
$15.1K Buy
2,774
+396
+17% +$2.22K ﹤0.01% 2100
2025
Q4
$17K Buy
2,378
+685
+40% +$5.36K ﹤0.01% 2006
2025
Q3
$13K Hold
1,693
﹤0.01% 1557
2025
Q2
$15K Buy
+1,693
New +$12.3K ﹤0.01% 1629
2022
Q4
Sell
-299,825
Closed -$7.6M 925
2022
Q3
$7.6M Sell
299,825
-36,341
-11% -$1.27M 0.03% 455
2022
Q2
$11.2M Buy
336,166
+146,396
+77% +$6.22M 0.04% 389
2022
Q1
$13.7M Buy
189,770
+80,021
+73% +$5.76M 0.05% 362
2021
Q4
$10.1M Buy
109,749
+48,012
+78% +$5.74M 0.03% 443
2021
Q3
$7.83M Sell
61,737
-1,028
-2% -$150K 0.03% 455
2021
Q2
$10.4M Sell
62,765
-46,621
-43% -$7.55M 0.04% 430
2021
Q1
$19.9M Buy
109,386
+23
+0% +$5.33K 0.08% 292
2020
Q4
$21.9M Buy
109,363
+51,572
+89% +$10.5M 0.1% 235
2020
Q3
$12.7M Sell
57,791
-136,427
-70% -$28.9M 0.07% 288
2020
Q2
$37.1M Sell
194,218
-17,127
-8% -$3M 0.25% 111
2020
Q1
$32.8M Sell
211,345
-333,683
-61% -$38.8M 0.28% 102
2019
Q4
$45.6M Buy
545,028
+127,684
+31% +$9.72M 0.31% 88
2019
Q3
$28.3M Buy
417,344
+143,350
+52% +$9.43M 0.22% 127
2019
Q2
$18.2M Buy
273,994
+218,398
+393% +$12.7M 0.15% 186
2019
Q1
$3.09M Buy
+55,596
New +$3.39M 0.03% 542

Other funds holding TDOC

BNP Paribas Asset Management's TDOC Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Teladoc Health (TDOC) stake by 14% in Q2 2026, selling an estimated $2.61K and leaving 2,382 shares worth $20.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2048.

BNP Paribas Asset Management first reported a position in TDOC in Q1 2019 and has held it in 20 quarters since. The position peaked at $45.6M in Q4 2019. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • BNP Paribas Asset Management held 2,382 shares of Teladoc Health worth $20.2K as of Q2 2026.
  • BNP Paribas Asset Management sold 392 Teladoc Health shares in Q2 2026, an estimated $2.61K.
  • Teladoc Health made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #2048 holding.
  • BNP Paribas Asset Management first reported a position in Teladoc Health in Q1 2019 and has held it in 20 quarters since.
  • BNP Paribas Asset Management's Teladoc Health position peaked at $45.6M in Q4 2019.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.